Orthofix International (OFIX) Misses Q1 EPS by 19c
Get Alerts OFIX Hot Sheet
Price: $9.29 -0.21%
Revenue Growth %: +3.6%
Financial Fact:
Net sales: 98.5M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +3.6%
Financial Fact:
Net sales: 98.5M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Orthofix International (NASDAQ: OFIX) reported Q1 EPS of ($0.10), $0.19 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $106.4 million versus the consensus estimate of $104.35 million.
GUIDANCE:
Orthofix International sees Q2 2022 EPS of $0.58-$0.73, versus the consensus of $0.66. Orthofix International sees Q2 2022 revenue of $475-490 million, versus the consensus of $481.93 million.
For earnings history and earnings-related data on Orthofix International (OFIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Asana, Inc. (ASAN) Tops Q2 EPS by 1c; offers guidance
- John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share